Ranbaxy Labs Q4CY11 revenues seen up 48% to Rs 3156cr

Ranbaxy Laboratories is to announce its Q4CY11. According to CNBC-TV18 estimates, the company's Q4CY11 revenues are seen up 48% to Rs 3156 crore versus Rs 2129 crore.

February 23, 2012 / 14:45 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

By Ekta Batra, CNBC-TV18

Ranbaxy Laboratories is to announce its Q4CY11. According to CNBC-TV18 estimates, the company's Q4CY11 revenues are seen up 48% to Rs 3156 crore versus Rs 2129 crore. Its EBITDA at Rs 832 crore versus Rs 230 crore. Its OPM 26.4% versus 10.8%. The company's PAT is seen at Rs 575 crore versus loss of Rs 97.5 crore.
first published: Feb 23, 2012 09:40 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!